Pascale Beurdeley

Pascale Beurdeley (Fehlbaum) is a seasoned professional in the field of biomedicine, currently serving as the Senior Vice President of Product Development at Depixus since April 2023, leading teams in the development and industrialization of pioneering genomic analysis technologies. Previously, Pascale held the position of Chief Scientific Officer at PathoQuest, where strategic scientific initiatives established partnerships with leading biotechnology firms. Extensive experience also includes roles as Executive Director of R&D at DIAXONHIT, Director of Molecular Diagnostic and Genomic Services, and Group Leader R&D at Exonhit Therapeutics, where Pascale contributed to significant advancements in diagnostics and biomarker discovery. Early career experience includes postdoctoral research positions in translational medicine and pharmaceutical development, complemented by academic achievements culminating in a Ph.D. from the University of Strasbourg, focused on immune responses in insects.